GPR39 and postmenopausal osteoporosis: Building upon earlier evidence demonstrating that GPR39 supports trabecular bone mass and matrix quality in male mice (Jovanovic et al. 2018), the present work expands these findings by characterizing its role in female and ovariectomized (OVX) mice—models pertinent to postmenopausal osteoporosis.